Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Alembic is voluntarily recalling one lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level.
read more
Charles River has completed the previously announced acquisition of Cognate BioServices for approximately $875 million.
read more
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the appointment of Dr. Martin Kessler as Chief Executive Officer (CEO) of Rentschler Biopharma Inc., the ...
read more
StemExpress is excited to announce that we will be opening our eighth facility with our newest location in Reno, Nevada.
read more
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a manufacturing agreement expansion with AstraZeneca to include drug product ...
read more
Patient-focused pharmaceutical company continues to partner with hospitals and ambulatory surgery centers to meet increased demand for essential compounded sterile medication during, and beyond, COVID-19; 503B outsourcing supports patient safety and ...
read more
Leading specialist development pharma, Amzell B.V, has signed a license and development agreement with Amring Pharmaceuticals Inc., a subsidiary of SEVER Life Sciences B.V., for the commercial rights to one of its leading clinical-stage candidates.
read more
Moderna, Inc. and Catalent, Inc. today announced the expansion of their strategic collaboration to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs in ...
read more
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology, a UK based bioconjugation development services business specialising in antibody drug conjugates (ADCs).
read more
Inotiv, Inc. announced today, an agreement to partner with Japan-based PhoenixBio Co., Ltd., to provide research services in Inotiv’s U.S. labs using PhoenixBio’s proprietary PXB-mouse® research model, a liver-humanized chimeric model used for drug ...
read more
The acquisition will add peptide API development and manufacturing capabilities.
read more
Partnership will provide access to Valence’s machine learning platform to accelerate preclinical drug discovery efforts.
read more
UL has launched an outreach program for governments and vaccine manufacturers to promote the safe and effective production, distribution, and administration of COVID-19 vaccines.
read more
Acquisition Further Expands Cryoport's Presence in Asia-Pacific Region to Address Increased Clinical Trial Activity Worldwide.
read more
Velocity Clinical Research announces today it has entered into an agreement with Global Healthcare Opportunities to be acquired from NaviMed Capital.
read more